Bahar Bybordi, MD
Obstetrics & Gynecology · Brooklyn, NYNPI 1548416589
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Sumitomo Pharma America, Inc. accounts for 63.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $5,956 and has fallen 84.0% since, to $955 in 2025. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $148.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$6K
- AbbVie$1K
- Astellas Pharma US Inc$485
- Baxter Healthcare$357
- Medtronic$266
- Hologic Sales And Service, LLC$169
- plus $798 from 11 others
What the payments were for
- Consulting fees$2002%
- Speaking & faculty fees$5,00056%
- Travel & lodging$2923%
- Food & beverage$3,30337%
- Education$1161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $5,621 |
| AbbVie | 12 | $1,217 |
| Astellas Pharma US Inc | 9 | $485 |
| Baxter Healthcare | 3 | $357 |
| Medtronic(2 entities) | 6 | $266 |
| Hologic Sales And Service, LLC | 4 | $169 |
| Davol Inc. | 1 | $155 |
| Biogen | 5 | $131 |
| Pfizer | 1 | $125 |
| Olympus America Inc. | 1 | $102 |
| Shield Therapeutics Inc | 3 | $59 |
| Merck | 2 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| Ascendis Pharma Endocrinology Inc | 2 | $42 |
| Intuitive Surgical | 1 | $40 |
| Bayer | 1 | $25 |
| Myovant Sciences Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$793
- MYFEMBREE$596
- STARLING SYSTEM$289
- Veozah$265
- ORIAHNN$145
- NURTEC ODT$125
- ThunderBeat$102
How this compares
$8,912 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 33 | $2,629 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 110 | $1,969 |
| Terconazole | 24 | $582 |
| Estradiol | 14 | $421 |
| Metronidazole | 11 | $193 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Brooklyn
- Miriam CremerBrooklyn$196K
- Michael LewisBrooklyn$62K
- Kathleen MorrellBrooklyn$48K
- Mark DefazioBrooklyn$27K
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Rachel MaschNew York$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.